Should I buy or sell Microbix Biosystems stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Microbix Biosystems in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" MBX shares. View MBX analyst ratings or view top-rated stocks .

How have MBX shares performed in 2024?

Microbix Biosystems' stock was trading at C$0.39 at the beginning of 2024. Since then, MBX stock has decreased by 10.3% and is now trading at C$0.35. View the best growth stocks for 2024 here .

When is Microbix Biosystems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our MBX earnings forecast .

How were Microbix Biosystems' earnings last quarter?

Microbix Biosystems Inc. (TSE:MBX) announced its earnings results on Wednesday, February, 14th. The company reported $0.02 earnings per share for the quarter. The firm earned $8.41 million during the quarter, compared to analysts' expectations of $8.10 million. Microbix Biosystems had a net margin of 16.57% and a trailing twelve-month return on equity of 14.66%.

What other stocks do shareholders of Microbix Biosystems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Microbix Biosystems investors own include TransAlta Renewables (RNW) , Organigram (OGI) , Dynavax Technologies (DVAX) , Heat Biologics (HTBX) , VEON (VEON) , Vaxart (VXRT) , Wajax (WJX) , BlackBerry (BB) and Canadian Western Bank (CWB) .

How do I buy shares of Microbix Biosystems?

Shares of MBX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

TSE:MBX

Microbix Biosystems (MBX) Stock Price, News & Analysis

→ Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad)

Free MBX Stock Alerts

C$0.35

0.00 (0.00%)

(As of 04/16/2024 ET)

Compare

Today's Range: C$0.35
▼
C$0.36
50-Day Range: C$0.35
▼
C$0.43
52-Week Range: C$0.23
▼
C$0.47

Volume: 15,026 shs
Average Volume: 73,456 shs
Market Capitalization: C$47.79 million

P/E Ratio: 11.67
Dividend Yield: 2.30%
Price Target: N/A

Stock Analysis Analyst Forecasts Chart Competitors Earnings Headlines Insider Trades

Get Microbix Biosystems alerts:

Ad Manward Press

Can't believe it's happening again

One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.

We explain how this event works in full right here.

About Microbix Biosystems Stock (TSE:MBX)

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

MBX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

MBX Stock News Headlines

April 11, 2024 | finance.yahoo.com

Microbix Presenting at the 2024 Bloom Burton Conference

April 1, 2024 | finance.yahoo.com

Microbix Announces Annual and Special Meeting Voting Results

April 16, 2024 | Manward Press (Ad)

Can't believe it's happening again

March 14, 2024 | finance.yahoo.com

Microbix’s Clot-Buster Drug Project Advances

March 11, 2024 | finanznachrichten.de

Microbix Biosystems Inc.: Microbix Unveils Test Controls for Head and Neck Cancer

March 11, 2024 | ca.finance.yahoo.com

Stocks in play: Microbix Biosystems Inc.

March 1, 2024 | wsj.com

Microbix Biosystems Inc.

February 26, 2024 | finance.yahoo.com

Microbix Announces Issuance of Stock Options

April 16, 2024 | Manward Press (Ad)

Can't believe it's happening again

February 17, 2024 | finance.yahoo.com

Microbix Biosystems First Quarter 2024 Earnings: EPS: CA$0.018 (vs CA$0.009 loss in 1Q 2023)

February 14, 2024 | finanznachrichten.de

Microbix Biosystems Inc.: Microbix Reports Record Results for Q1 Fiscal 2024

February 14, 2024 | finance.yahoo.com

Microbix Reports Record Results for Q1 Fiscal 2024

February 7, 2024 | finance.yahoo.com

Microbix Schedules Release of Results for Q1 Fiscal 2024

February 6, 2024 | finanznachrichten.de

Microbix Biosystems Inc.: Microbix Unveils Test Control for Gastric Ulcer Disease Pathogen

February 6, 2024 | finance.yahoo.com

Microbix Unveils Test Control for Gastric Ulcer Disease Pathogen

January 3, 2024 | finance.yahoo.com

Microbix Achieves Further QAPs Sales Record

December 22, 2023 | finance.yahoo.com

Microbix Biosystems Full Year 2023 Earnings: Revenues Miss Expectations

December 21, 2023 | finance.yahoo.com

Microbix Reports Results for Q4 & Full-Year Fiscal 2023

December 14, 2023 | finance.yahoo.com

Microbix & Seegene USA Jointly Enhancing Lab Test Accuracy

December 7, 2023 | finance.yahoo.com

Microbix & BioGX Collaborate on real-time PCR Assays & Controls

November 17, 2023 | financialpost.com

Microbix Presenting at Florida Capital Event Conference

November 16, 2023 | finanznachrichten.de

Microbix Biosystems Inc.: Microbix Clot-Buster Drug Fully-Funded For Return to U.S. Market

November 16, 2023 | finance.yahoo.com

Microbix Clot-Buster Drug Fully-Funded For Return to U.S. Market

November 10, 2023 | finance.yahoo.com

Microbix & Ulisse Biomed Collaborate on HPV Controls & Assays

October 27, 2023 | finance.yahoo.com

Microbix QAPs Supporting HPV Testing in Ireland

October 21, 2023 | investing.com

Microbix Biosystems Inc. (MBX)

September 27, 2023 | finance.yahoo.com

Microbix Achieves New QAPs Sales Record

See More Headlines

Receive MBX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Microbix Biosystems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/14/2024
Today: 4/16/2024
Next Earnings (Estimated): 5/09/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: TSE
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: TSE:MBX
CUSIP: N/A
CIK: N/A
Web: microbix.com
Phone: +1-905-3618910
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): C$0.03
Trailing P/E Ratio: 11.67
Forward P/E Ratio: 17.48
P/E Growth: N/A
Net Income: C$3.72 million
Net Margins: 16.57%
Pretax Margin: N/A
Return on Equity: 14.66%
Return on Assets: 1.87%

Debt

Debt-to-Equity Ratio: 24.53
Current Ratio: 8.53
Quick Ratio: 5.57

Sales & Book Value

Annual Sales: C$22.42 million
Price / Sales: 2.13
Cash Flow: C$0.08 per share
Price / Cash Flow: 4.13
Book Value: C$0.20 per share
Price / Book: 1.75

Miscellaneous

Outstanding Shares: 136,550,000
Free Float: N/A
Market Cap: C$47.79 million
Optionable: Not Optionable
Beta: 0.28

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

Mr. Cameron L. Groome
President, CEO & Director
Mr. James S. Currie
Chief Financial Officer
Dr. Kenneth Hughes Ph.D.
Chief Operating Officer
Dr. Mark Luscher Ph.D.
Senior Vice President of Scientific Affairs
Mr. Philip Casselli
Senior Vice President of Sales, Business Development & Marketing
Mr. Christopher B. Lobb
Compliance Officer, General Counsel & Secretary

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

MBX Stock Analysis - Frequently Asked Questions

Should I buy or sell Microbix Biosystems stock right now?: 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Microbix Biosystems in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" MBX shares.
View MBX analyst ratings or view top-rated stocks.
How have MBX shares performed in 2024?: Microbix Biosystems' stock was trading at C$0.39 at the beginning of 2024. Since then, MBX stock has decreased by 10.3% and is now trading at C$0.35.
View the best growth stocks for 2024 here.
When is Microbix Biosystems' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our MBX earnings forecast.
How were Microbix Biosystems' earnings last quarter?: Microbix Biosystems Inc. (TSE:MBX) announced its earnings results on Wednesday, February, 14th. The company reported $0.02 earnings per share for the quarter. The firm earned $8.41 million during the quarter, compared to analysts' expectations of $8.10 million. Microbix Biosystems had a net margin of 16.57% and a trailing twelve-month return on equity of 14.66%.

What other stocks do shareholders of Microbix Biosystems own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Microbix Biosystems investors own include TransAlta Renewables (RNW), Organigram (OGI), Dynavax Technologies (DVAX), Heat Biologics (HTBX), VEON (VEON), Vaxart (VXRT), Wajax (WJX), BlackBerry (BB) and Canadian Western Bank (CWB).
How do I buy shares of Microbix Biosystems?: Shares of MBX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:MBX) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Microbix Biosystems (MBX) Stock Price, News & Analysis

About Microbix Biosystems Stock (TSE:MBX)

MBX Stock Price History

MBX Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

MBX Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info